# US 2023/0414123 A1 · System and method for measuring blood flow velocity on a microfluidic chip

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0414123 A1
- Document ID: US20230414123A1
- Status: Published application
- Kind: A1
- Application number: 18/037,472
- Filed: 2021-11-17
- Published: 2023-12-28
- Earliest claimed: 2020-11-17
- Assignees: Case Western Reserve University
- Applicants: Case Western Reserve University
- Inventors: Bryan SCHMIDT; Umut GURKAN; Erdem KUCUKAL; Yucheng MAN
- Web page: https://patentgrep.com/patent/US20230414123A1

## CPC

- A61B 5/0285: Measuring or recording phase velocity of blood waves
- G01N 33/4905: {Determining clotting time of blood (by chemical methods G01N33/86, C12Q1/56)}
- G06T 7/0016: {involving temporal comparison}
- G16H 30/20: for handling medical images, e.g. DICOM, HL7 or PACS
- G01N 27/447: using electrophoresis
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G06T: IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

This application describes a microfluidic system for measuring blood flow velocity using particle image velocimetry (PIV) and wavelet-based optical flow velocimetry (wOFV) processing to determine one or more hemodynamic parameters. The hemodynamic parameters can include whole blood rheology as well as spatiotemporal variations in blood velocity, respectively, during coagulation in flowing blood samples. The system can provide quantitative information on the formation and evolution of thrombi, identify subjects with clotting disorders associated with abnormal thrombus growth rate, and/or determine the effect of therapeutics and/or therapeutical approaches on clotting dynamics and thrombus formation.

## Claims

### Claim 1

A system comprising:
a microfluidic device having at least one microchannel through which a blood sample flows;
a camera configured to obtain a plurality of images of the blood sample flowing through the microchannel; and
a processor configured to determine one or more hemodynamic parameters based on differences between two sets of consecutive images of the plurality of images, wherein the processor uses particle image velocimetry (PIV) of a first set of consecutive images to determine temporal evolution of mean blood flow velocity and wavelet-based optical flow velocimetry (wOFV) of a second set of consecutive images to determine a blood flow velocity field.

### Claim 2 (depends on 1)

The system of claim 1, wherein the PIV and wOFV use images of individual blood cells of the flowing blood sample as flow tracers to estimate velocity.

### Claim 3 (depends on 1)

The system of claim 1, wherein the processor is configured to calculate clotting time and decay rate based on the temporal evolution of the mean flow velocity.

### Claim 4 (depends on 1)

The system of claim 1, wherein the processor is configured to identify blood flow channels around thrombi formed in the microchannel by the velocity field generated by wOFV.

### Claim 5 (depends on 1)

The system of claim 1, wherein the processor is configured to pre-process the images prior to PIV and wOFV, wherein the pre-processing includes mean filtering intensity normalization, and edge-aware Laplacian filtering.

### Claim 6 (depends on 5)

The system of claim 5, wherein the mean filtering reduces image noise and the intensity normalization and edge-aware Laplacian filtering improve motion estimation of the images.

### Claim 7 (depends on 1)

The system of claim 1, wherein the processor is configured to segment a first image and a second image of the first set of images into a plurality of interrogation regions, cross-correlate each of the plurality of interrogation regions, and identify one more velocity vectors based on the cross-correlated interrogation regions for PIV.

### Claim 8 (depends on 1)

The system of claim 1, wherein the processor is configured to superimpose velocity vectors or streamlines on the blood flow velocity field determined by wOFV to determine residence time of a blood cell along flow path in the microchannel

### Claim 9 (depends on 1)

The system of claim 1, channel having at least one functionalized adhesion region adapted to adhere to blood cells of interest within the blood sample.

### Claim 10 (depends on 1)

The system of claim 1, comprising at least two cameras that provide staggered image acquisition of the blood flowing through the microchannel

### Claim 11 (depends on 10)

The system of claim 10, wherein two cameras are attached to a beamsplitter unit, such that each camera has an identical view of the microchannel, wherein both cameras operate at continuous framing but are triggered such that the second camera acquires its images a time Δt after the images acquired by the first camera, and wherein the processor compares images from the first camera to images of the second camera.

### Claim 12

A method of determining one or more hemodynamics of a blood sample, the method comprising:
obtaining a plurality of images of the blood sample flowing through a microchannel of a microfluidic device; and
determining one or more hemodynamic parameters based on differences between two sets of consecutive images of the plurality of images, wherein the processor uses particle image velocimetry (PIV) processing of a first set of consecutive images to determine temporal evolution of mean blood flow velocity and wavelet-based optical flow velocimetry (wOFV) processing of the second set of consecutive images to determine a blood flow velocity field.

### Claim 13 (depends on 12)

The method of claim 12, further estimating flow velocity for the PIV and wOFV by identifying individual blood cells of the flowing blood sample.

### Claim 14 (depends on 12)

The method of claim 12, further comprising calculating clotting time and decay rate based on the temporal evolution of the mean flow velocity determined by PIV.

### Claim 15 (depends on 12)

The method of claim 12, further comprising identifying blood flow channels around thrombi formed in the microchannel by the velocity field generated by wOFV.

### Claim 16 (depends on 13)

The method of claim 13, further applying one of mean filtering, intensity normalization, and edge-aware Laplacian filtering to the images prior to PIV and/or wOFV.

### Claim 17 (depends on 12)

The method of claim 12, further comprising segmenting a first image and a second image of the first set of images into a plurality of interrogation regions, cross-correlating each of the plurality of interrogation regions, and identifying one more velocity vectors based on the cross-correlated interrogation regions for PIV.

### Claim 18 (depends on 12)

The method of claim 12, further comprising superimposing velocity vectors or streamlines on the blood flow velocity field determined by wOFV to determine residence time of a blood cell along flow path in the microchannel.

### Claim 19 (depends on 12)

The method of claim 12, wherein the microchannel has at least one functionalized adhesion region adapted to adhere to blood cells of interest within the blood sample.

### Claim 20 (depends on 12)

The method of claim 12, wherein the plurality of images are obtained by two cameras that provide staggered image acquisition of the blood flowing through the microchannel, wherein both cameras operate at continuous framing but are triggered such that the second camera acquires its images a time At after the images acquired by the first camera.

### Claim 21 (depends on 20)

The method of claim 20, further comprising comparing images from the first camera to images of the second camera.
